Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test

Psychopharmacology

Volumn 138, Issue 2, 1998, Pages 198-206

  Redrobe, John P ^a   Bourin, Michel ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Buspirone 1 PP; Mouse forced swimming test; Selective serotonin reuptake inhibitor

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BUSPIRONE; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FORCED SWIMMING TEST; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY;

ANIMALS; ANTIDEPRESSIVE AGENTS; BUSPIRONE; CITALOPRAM; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXERCISE TEST; FLUOXETINE; FLUVOXAMINE; MALE; MICE; MOTOR ACTIVITY; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SWIMMING;

EID: 0031872388     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050663     Document Type: Article

References (46)

1. Armitage P, Berry G (1987) Statistical methods in medical research, 2nd edn. Blackwell, Oxford, pp 203 205
2. Artigas F (1995) Pindolol, 5-hydroxytryptamine, and antidepressant augmentation. Arch Gen Psychiatry 52:969-971
3. 1A antagonists. Trends Neurosci 19:378-383
4. 1A-agonistic effects of the new antidepressant mirtazapine. Psychopharmacology 133:275-282
5. Blier P, Bergeron R (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 15:217-222
6. Blier P, De Montigny C (1985) Serotonergic but not noradrenergic neurons in the rat central nervous system adapt to long term treatment with monoamine oxidase inhibitors. Neuroscience 16:949-955
7. Boissier JR, Simon P (1965) Action de la caféine sur la motilité spontanée dela souris. Arch Int Pharmacodyn 158:212 221
8. Borsini F (1995) Role of the serotonergic system in the forced swimming test. Neurosci Biobehav Rev 19:377-395
9. 1c receptor function. Eur J Pharmacol 203:359-363
10. 1A receptors in augmenting antidepressant activity in the mouse forced swimming test. Psychopharmacology 138:226 234
11. Caccia S, Garattini A, Mancinelli, Muglia M (1982) Identification and quantitation of 1-(2-pyrimidinyl)-piperazine, an active metabolite of the anxiolytic agent buspirone, in rat plasma and brain. J Chromatogr 252:310-314
12. Caccia S, Muglia M, Mancinelli A, Garattini S (1983) Disposition and metabolism of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in the rat. Xenobiotica 13:147-153
13. Caccia S, Fong MH, Guiso G (1985) Disposition of the psychotropic drugs buspirone, MJ-13805 and piribedil, and of their common active metabolite 1-(2-pyrimidinyl)-piperazine in the rat. Xenobiotica 15:835 844
14. Caccia S, Conti I, Vigano G, Garattini S (1986) 1-(2-pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat. Pharmacology 33:46-51
15. Cervo L, Samanin R (1987) Potential antidepressant properties of 8-OH-DPAT, a selective serotonin 1A receptor agonist. Eur J Pharmacol 144:223-229
16. 2-adrenoreceptor blockade prevents the effect of desipramine in the forced swimming test. Eur J Pharmacol 175:301-307
17. Cesana R, Ceci A, Ciprandi C, Borsini F (1993) Mesulergine antagonism towards the fluoxetine anti-immobility effect in the forced swimming test in mice. J Pharm Pharmacol 45:473-475
18. Da Rocha MA, Puech AJ, Thiébot MH (1997) Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice. J Psychopharmacol 11:211-218
19. Detke MJ, Johnson J, Lucki I (1997) Acute and chronic antidepressant treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 5:107-112
20. 1A agonists. Biol Psychiatry 23:237-242
21. 1A agonists in the forced swimming test. Prog Neuro-Psychopharmacol Biol Psychiatry 18:381-396
22. Hjorth S (1996) (-)-Pindolol. but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine. Eur J Pharmacol 303:183-186
23. 1A receptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis. Neuropharmacology 33:331-334
24. Hjorth S, Carlsson A (1986) Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? Eur J Pharmacol 129:131-138
25. 1B autoreceptor blocking properties of the beta-adrenoreceptor antagonist (-)penbutolol. J Pharmacol Exp Ther 265:707-712
26. 1 recognition sites. J Receptor Res 8:59-81
27. Jacobsen FM (1991) Possible augmentation of antidepressant response by buspirone. J Clin Psychiatry 52:217-220
28. Jajoo HK, Mayol RF, Labudde JA, Blair IA (1989) Metabolism of the antianxiety drug buspirone in the rat. Drug Metab Dispos 17:625-633
29. Joffe RT, Schuller DR (1993) An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. J Clin Psychiatry 54:269-271
30. Kennett GA, Curzon G (1989) Mechanism of action of 8-OH-DPAT on a rat model of human depression. In: Bevan P, Cools A, Archer T (eds.) Behavioral pharmacology of 5-HT. Erlbaum, New Jersey, pp 225-229
31. Kennett GA, Dickson SL, Curzon G (1985) Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats. Brain Res 330:253-263
32. 1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur J Pharmacol 138: 53 60
33. Keuls M (1952) The use of studentized range in connection with an analysis of variance. Euphytica 1:112-122
34. 3 receptors. J Psychopharmacol 11[Suppl 3]:A31
35. Lucki I (1991) Behavioral studies of serotonin receptor agonists as antidepressant drugs. J Clin Psychiatry 52 [Suppl]: 24-31
36. 1A receptors. Eur J Pharmacol 294:617-624
37. 1A agonists in the learned helplessness paradigm in rats. Psychopharmacology 104:275-278
38. Mennini T, Caccia S, Garattini S (1987) Mechanism of action of anxiolytic drugs. Prog Drug Res 31:315-347
39. Porsolt RD, Bertin A, Jalfre M (1977) Behavioural despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn 229:327-336
40. 1A receptor ligands in a chronic mild stress model of depression. Neuropharmacology 34:1310-1995
41. 3 receptors in the activity of antidepressants in the mouse forced swimming test. Eur J Pharmacol 325:129-135
42. 1B receptors with antidepressant drugs in the mouse forced swimming test. Eur J Pharmacol 318:213-220
43. Rimele TJ, Henry DE, Lee DKH, Geiger G, Heaslip RJ, Grimes D (1987) Tissue-dependent alpha-adrenoreceptor activity of buspirone and related compounds. J Pharmacol Exp Ther 241: 771-778
44. Robinson DS, Alms DR, Shrotriya RC, Messina ME, Wickramaratre P (1989) Serotonergic anxiolytics and treatment of depression. Psychopathology 22 [Suppl 1]:22-36
45. 1A receptor antagonist WAY100135 - an in vivo microdialysis study. Eur J Pharmacol 239:195-202
46. Thiebot MH, Martin P, Puech AJ (1992) Animal behavioural studies in the evaluation of antidepressant drugs. Br J Psychiatry 15 [Suppl]:44-50